Every investor in Silence Therapeutics plc (NASDAQ:SLN) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 44% to be precise, ...
Hosted on MSN
Why I'm So Disappointed In Marvel's Spider-Man 2
Over 30 suits were cut from Marvel's Spider-Man 2, focusing on original designs at the expense of classic favorites. Peter and Miles having equal suits felt nonsensical as Peter's character history ...
Silence Therapeutics plc (NASDAQ:SLN) missed earnings with its latest quarterly results, disappointing overly-optimistic forecasters. Statutory earnings fell substantially short of expectations, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback